semaglutide mash FDA Approves Wegovy® as First Treatment Complementary mechanistic pathways of resmetirom

This early response might be due to mechano-insensitive afferents (MIAs)

Sweating therapies Sweating is one of the bodys pathways for detoxification that can help facilitate the elimination of toxins

Glutathione and catalase provide overlapping defenses for protection against respiration-generated hydrogen peroxide in Haemophilus influenzae

Cerovecki T, Bojanic I, et al

Active Loss Phase (3-12 Months): Strategic Volume Replacement As weight loss progresses and facial changes become apparent, strategic use of dermal fillers can maintain facial harmony

In 2026, there's one main FDA-approved oral GLP-1 on the market (oral semaglutide), with another promising oral option (orforglipron) approaching the finish line but with a reputation for rougher GI tolerability in trials